Clinical status of reproductive aged women with combined pathology of the uterus – leiomyoma and adenomyosis
Keywords:combined uterine pathology, uterine leiomyoma, adenomyosis
Clinical assessment of the general status of patients with combined uterine pathology (leiomyoma (LM) and adenomyosis) has a practical importance for determining specific therapeutic tactics. The study of the general condition of reproductive aged women with this pathology allows determining of many factors that can affect the clinical course of disease.
Purpose of the study was to investigate the clinical status of reproductive aged women who suffer from combined uterine pathology – LM and adenomyosis.
Materials and methods. 120 women of reproductive age were examined. Group IA united 60 patients with combined uterine pathology – asymptomatic LM and nodal, diffuse, diffuse-focal adenomyosis III, IV degrees of severity with active clinical course; group IB united 60 patients with combined uterine pathology - symptomatic LM and diffuse, diffuse focal adenomyosis I, II degrees of severity with inactive clinical course. Examination was carried out in accordance with the orders of the Ministry of Health of Ukraine.
Results. A study of the general status of reproductive aged women has revealed many factors that can affect the clinical course of disease. The study of nosological forms of extragenital pathology revealed a wide range of different organs and systems diseases, co-morbidities of mainly chronic course, varying severity in 100% of women. A number of somatic diseases can be both a cause and a consequence of gynecological pathology, especially hormonal etiology. Analysis of the anamnestic data on the transferred gynecological diseases showed 100% frequency of the combined and concomitant pathology of the female genital tract.
Conclusions. Completed study involving reproductive aged women with combined uterine pathology (LM and adenomyosis) showed many factors that can affect the clinical course of disease. Obtained data indicate that there are complex metabolic disorders in the women’s body suffering from that combined uterine pathology.
- Adamyan, L.V. “Medical and social aspects of genital endometriosis.” Reproduction Problems 6 (2011): 78–81.
- Anichkov, N.M., Pechenikova, V.A. “Combination of adenomyosis and uterine leiomyoma.” Pathology Archive 3.67 (2005): 31–4.
- Bizova, T.E., Sevastyanova, O.Y., Sudarikova, E.G. “Clinical and anamnestic features of uterine leiomyoma in reproductive aged women.” Ukr Med Journal 10 (2009): 78–81.
- Vikhlyaeva, E.M., Zheleznov, B.I., Zaporozhan, V.N. Endocrine Gynecology Guideline. Moscow. Medical News Agency (2008): 768 p.
- Strizhakov, A.N. Benign uterus diseases. 2nd ed., revised and add. Moscow. GEOTAR-Media (2014): 312 p.
- Kulakov, V.I., Manukhin, I.B., Savelieva, G.M. Gynecology. National Guideline. Moscow. GEOTAR-Media (2009): 265 p.
- Tatarchuk, T.F., Kosey, N.V., Tutchenko, T.N. “Uterine fibroids and the reproductive function of women: a critical assessment of therapeutic approaches.” Reproductive Endocrinology 1 (2011): 56–63.
- Tatarchuk, T.F., Zakharenko, N.F., Tutchenko, T.N. “New approaches to the problematic issues of treatment of genital endometriosis.” Reproductive Endocrinology 3 (2013): 36–42.
- Willengsen, W.N. “Fibroids and fertility.” Ned Tijdschr Geneeskd 144 (2010): 789–91.
- Zaporozhchenko, B.S., Kolodiy, V.V., Gorbunov, A.A., et al. “Lifting laparoscopy in simultaneous surgery.” Clinical surgery 3 (2017): 5–8.
- Antypkin, Y.G., Vdovychenko, Y.P., Graziottin, A., et al. "Uterine bleedings and quality of woman's life: Resolution of advisory board." Reproductive Endocrinology 3.47 (2019): 13–8.
- Donnez, J., Tatarchuk, T.F., Bouchard, P., et al. “Ulipristal acetate versus placebo for fibroid treatment before surgery.” New England Journal of Medicine 366.5 (2012): 409–20.
- Taran, F.A., Weaver, A.L., Coddington, C.C., Stewart, E.A. “Characteristics indicating adenomyosis coexisting with leiomyomas: a case-control study.” Hum Reprod 25.5 (2010): 1177–82. doi: 10.1093/humrep/deq034
- Ali İrfan Guzel, Burak Akselim, Selçuk Erkılınç, et al. “Risk factors for adenomyosis, leiomyoma and concurrent adenomyosis and leiomyoma.” The Journal of Obstetrics & Gynecology research (2015). doi: 10.1111/jog.12635.
- Weiss, G., Maseelall, P., Schott, L.L., et al. “Adenomyosis a variant, not a disease? Evidence from hysterectomized menopausal women in the Study of Women's Health Across the Nation (SWAN).” Fertil Steril 91 (2009): 201–6.
- Parazzini, F., Mais, V., Cipriani, S., et al. “Determinants of adenomyosis in women who underwent hysterectomy for benign gynecological conditions: results from a prospective multicentric study in Italy.” Eur J Obstet Gynecol Reprod Biol 143 (2009): 103–6.
- Brucker, S.Y., Huebner, M., Wallwiener, M., et al. “Clinical characteristics indicating adenomyosis coexisting with leiomyomas: a retrospective, questionnaire-based study.” Fertil Steril 101.1 (2014): 237–41. doi: 10.1016/j. fertnstert.2013.09.038
- Levgur, M., Abadi, M.A., Tucker, A. “Adenomyosis: symptoms, histology, and pregnancy terminations.” Obstet Gynecol 95 (2000): 688–91.
- Martinez-Conejero, J.A., Morgan, M., Montesinos, M., et al. “Adenomyosis does not affect implantation, but is associated with miscarriage in patients undergoing oocyte donation.” Fertil Steril 96 (2011): 943–50.
- Taran, F.A., Weaver, A.L., Coddington, C.C., Stewart, E.A. “Characteristics indicating adenomyosis coexisting with leiomyomas: a case-control study.” Hum Reprod 25 (2010): 1177–82.
- Vlahos, N.F., Theodoridis, T.D., Partsinevelos, G.A. “Myomas and Adenomyosis: Impact on Reproductive Outcome.” Biomed Res Int (2017). doi: 10.1155/2017/5926470
- Tasuku Harada, Yin Mon Khine, Apostolos Kaponis, et al. “The Impact of Adenomyosis on Women's Fertility.” Obstet Gynecol Surv 71.9 (2016): 557–68. doi: 10.1097/OGX.0000000000000346
- Segars, J.H., Parrott, E.C., Nagel, J.D., et al. “Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.” Hum Reprod Update 20.3 (2014): 309–33. doi: 10.1093/humupd/dmt058
- Commandeur, A.E., Styer, A.K., Teixeira, J.M. “Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.” Hum Reprod Update 2.15 (2015): 593–615. doi: 10.1093/humupd/dmv030
- Wegienka, G., Baird, D.D., Cooper, T., et al. “Cytokine Patterns Differ Seasonally between Women with and without Uterine Leiomyomata.” Am J Reprod Immunol 70 (2013): 327–35.
How to Cite
Copyright (c) 2019 М. Б. Запорожченко, А. В. Сидоренко, Д. Ю. Парубіна
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.